CFO4Life Group LLC Reduces Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

CFO4Life Group LLC lowered its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.7% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,528 shares of the healthcare conglomerate’s stock after selling 43 shares during the period. CFO4Life Group LLC’s holdings in UnitedHealth Group were worth $1,279,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in UNH. NewSquare Capital LLC purchased a new stake in shares of UnitedHealth Group in the 4th quarter worth about $25,000. AlphaMark Advisors LLC purchased a new stake in shares of UnitedHealth Group in the 4th quarter worth about $30,000. Promus Capital LLC purchased a new stake in shares of UnitedHealth Group in the 4th quarter worth about $32,000. RPg Family Wealth Advisory LLC purchased a new stake in shares of UnitedHealth Group in the 3rd quarter worth about $37,000. Finally, Pillar Financial Advisors LLC purchased a new stake in shares of UnitedHealth Group in the 4th quarter worth about $40,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Buying and Selling at UnitedHealth Group

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the stock in a transaction dated Friday, January 17th. The shares were purchased at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Performance

UNH opened at $481.18 on Thursday. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a market cap of $440.14 billion, a price-to-earnings ratio of 31.04, a PEG ratio of 1.37 and a beta of 0.62. The company’s 50 day moving average is $512.33 and its 200 day moving average is $551.50. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm’s revenue was up 6.8% compared to the same quarter last year. During the same quarter last year, the firm posted $5.83 earnings per share. On average, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th will be issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.75%. The ex-dividend date is Monday, March 10th. UnitedHealth Group’s dividend payout ratio is currently 54.19%.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on the stock. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Wells Fargo & Company decreased their price target on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective for the company in a research note on Friday, January 10th. Hsbc Global Res upgraded shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. Finally, Piper Sandler reduced their price objective on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research note on Thursday, January 2nd. One investment analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.